Literature DB >> 21863673

Epidemiology of candidemia in Songklanagarind Hospital.

Noppawan Jutiamornlerd1, Sarunyou Chusri, Pisud Siripaitoon.   

Abstract

OBJECTIVE: To study the epidemiology of candidemia patients in Songklanagarind Hospital. MATERIAL AND
METHOD: A retrospective study examining the epidemiological data of candidemia patients in Songklanagarind Hospital, a referral center in southern Thailand, between January 2004 and December 2009.
RESULTS: Two hundred six candidemia inpatients had an overall 54% mortality rate. The median age of the patients was 53 years (range: 1-98 years). Length of hospital stay was an average of 55 days. Most of them (129, 62.6%) were admitted in a non-intensive care unit (non-ICU). The most common associated condition was solid organ malignancy (67, 32.5%). Most of the patients (181, 88%) had a history of broad spectrum antibiotic usage; however, in the non-broad spectrum antibiotics group solid organ malignancy was still the most common associated condition. Candida albicans and non-albicans Candida accounted for 83 (40.3%) and 123 (59.7%) cases, respectively. Higher mortality rates were significantly related with intensive care unit (ICU) admission, elderly patients, and the presence of solid organ tumors, hematologic malignancies, and neutropenia, and influenced by intubation with a mechanical ventilator, central venous or urethral catheterization, surgical procedures, and administration of antibiotics.
CONCLUSION: Candidemia can cause a high mortality rate that is influenced with many independent risk factors including surgical and medical interventions. Non-albicans Candida is more common than Candida albicans whereas each mortality rate was not significantly different.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21863673

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  1 in total

1.  Calcium-activated-calcineurin reduces the In vitro and In vivo sensitivity of fluconazole to Candida albicans via Rta2p.

Authors:  Yu Jia; Ren-Jie Tang; Lin Wang; Xiang Zhang; Ying Wang; Xin-Ming Jia; Yuan-Ying Jiang
Journal:  PLoS One       Date:  2012-10-30       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.